IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Rosalind Advisors, Inc.

Portfolio Profile

CIK: 0001622627 | TORONTO, A6

Investment Profile

Style

Growth

Turnover

High

Orientation

Concentrated trader
$266.2M
AUM
29
Positions
74.86%
Top 10 Conc.
98.71%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Delcath Systems, Inc.(DCTH)3,300,389$41.6M15.44%
2Fennec Pharmaceuticals Inc(FENC)3,188,001$34.3M12.73%
3Xeris Biopharma Holdings Inc(XERS)2,908,981$23.0M8.56%
4Savara Inc(SVRA)3,178,121$19.6M7.27%
5Verastem Inc(VSTM)3,986,509$15.2M5.66%
6

Sector Allocation

Latest filing, equity positions only

Healthcare94.19% · $250.8M
Unclassified5.81% · $15.5M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare93.67%94.19%+0.52%
Unclassified6.33%5.81%-0.52%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$121.4M | 30 pos.
$107.0M | 34 pos.
$130.0M | 40 pos.
$156.2M | 33 pos.
$195.6M | 40 pos.
$205.6M | 34 pos.
X4 Pharmaceuticals Inc(XFOR)
3,214,766
$15.0M
5.58%
7Eyepoint Pharmaceuticals Inc(EYPT)988,230$14.1M5.25%
8Cybin Inc(HELP)1,956,814$12.9M4.80%
9VOR Biopharma Inc(VOR)648,600$11.9M4.44%
10Vaxcyte Inc(PCVX)200,000$11.6M4.32%
Cap SizePrev %Curr %Change
Small Cap56.15%58.47%+2.32%
Micro Cap21.26%27.6%+6.34%
Mid Cap16.25%8.12%-8.13%
Unclassified6.33%5.81%-0.52%
$210.9M | 37 pos.
$292.6M | 39 pos.
$284.5M | 42 pos.
$248.9M | 38 pos.
$269.2M | 35 pos.
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

9
New
12
Closed
7
Increased
11
Decreased
8
Unchanged